Before the U.S. Supreme Court acted Friday, access to an abortion pill was in line to become more cumbersome in California, New York and some other states that have positioned themselves as safe havens for those seeking to end their pregnancies.
The order keeps in place federal rules for use of mifepristone, one of the two drugs usually used in combination in medication abortions. The legal saga isn’t over: The Supreme Court suggested it will decide the issue by Wednesday.
The high court’s position pauses a ruling issued last Wednesday by the 5th Circuit Court of Appeals in New Orleans that would have allowed mifepristone sales to continue, but under rules adopted by the Food and Drug Administration in 2000, before a series of changes that relaxed access.
The 5th Circuit ruling, which overturned another recent federal court order halting mifepristone sales nationwide, was set to take effect Saturday. It would have required the drug to be taken in the presence of a physician, ruling out mailing it to patients.
“That’s not good for all of these states that are trying to help other people,” Jolynn Dellinger, a senior lecturing fellow at Duke Law School who has been following the mifepristone litigation, said before the Supreme Court ruled.
None of the rulings affect the other abortion pill, misoprostol, which can be used alone to end pregnancies but is more effective when taken in combination with mifepristone.
For the 13 states with bans on abortion at all stages of pregnancy and the one with a ban on abortion after cardiac activity can be detected, reverting to the old rules would have had little to no effect on abortion policy.
At least 10 other states had restrictions that already placed limits on medication abortion, according to an analysis by the Kaiser Family Foundation. For instance, in Georgia, it’s legal only in the first six weeks of pregnancy; in Kansas, an ultrasound at an office visit is required before it’s dispensed; and in North Carolina, it can’t be prescribed via telehealth.
On the other side, 17 states controlled by Democrats apparently would not have been affected by the change either; in a separate but closely related case last week, a judge sided with them in their request that mifepristone access not be changed there.
That would have left just eight states where returning to the pre-2016 rules could have had a major impact: Democrat-controlled California, Massachusetts, New Jersey and New York — all states that have protected abortion access and allowed out-of-staters seeking abortions — Republican-controlled Alaska and Montana and politically divided New Hampshire and Virginia.
California, Massachusetts and New York have stockpiled abortion pills in case of restrictions, and Maryland’s governor announced Friday that his state was doing the same. New Jersey Gov. Phil Murphy has said he’s considering doing so.
Maryland Gov. Wes Moore, a Democrat, said his administration has partnered with the University of Maryland Medical System to ensure access to mifepristone.
“As a member of the Reproductive Freedom Alliance, Maryland will not stand for this assault on women’s health care,” Moore said. “This purchase is another example of our Administration’s commitment to ensure Maryland remains a safe haven for abortion access and quality reproductive health care.”